ranitidine recall
Selected indexed studies
- The 'burn' of ranitidine recall: current insights and mitigation strategies. (Eur J Gastroenterol Hepatol, 2021) [PMID:33867447]
- Medicine and Media: The Ranitidine Debate. (Clin Transl Sci, 2020) [PMID:32107850]
- N-nitrosodimethylamine (NDMA) contamination of ranitidine products: A review of recent findings. (J Food Drug Anal, 2021) [PMID:35696227]
_Worker-drafted node — pending editorial review._
Connections
ranitidine recall is a side effect of
Sources
- The 'burn' of ranitidine recall: current insights and mitigation strategies. (2021) pubmed
- Medicine and Media: The Ranitidine Debate. (2020) pubmed
- N-nitrosodimethylamine (NDMA) contamination of ranitidine products: A review of recent findings. (2021) pubmed
- Prescription ranitidine use and population exposure in 6 Canadian provinces, 1996 to 2019: a serial cross-sectional analysis. (2023) pubmed
- Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting system. (2025) pubmed
- Nitrosamine Contamination in Pharmaceuticals: Threat, Impact, and Control. (2021) pubmed
- Nitrosamine Impurities in Angiotensin Receptor Blockers. (2020) pubmed
- Mitigation of N-Nitrosamine formation in ranitidine hydrochloride by spray drying co-precipitation with mannitol, dextrin, and antioxidant. (2025) pubmed
- Prescription changes in patients with gastrointestinal disorders after withdrawal of ranitidine: a nationwide population-based cohort study. (2023) pubmed
- Major Shifts in Acid Suppression Drug Utilization After the 2019 Ranitidine Recalls in Canada and United States. (2023) pubmed